Projects per year
Fingerprint Dive into the research topics where Joseph Aisner is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 10 Similar Profiles
Small Cell Lung Carcinoma
Medicine & Life Sciences
Non-Small Cell Lung Carcinoma
Medicine & Life Sciences
Neoplasms
Medicine & Life Sciences
Therapeutics
Medicine & Life Sciences
Drug Therapy
Medicine & Life Sciences
Carboplatin
Medicine & Life Sciences
Lung Neoplasms
Medicine & Life Sciences
Megestrol Acetate
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects 2004 2015
- 1 Finished
Participation In The Eastern Cooperative Oncology Group
National Institutes of Health (NIH)
9/2/04 → 2/28/15
Project: Research project
Chemoprevention
Research Personnel
Clinical Trials
Guideline Adherence
Synthetic Vaccines
Research Output 1974 2019
A Novel Acquired Exon 20 EGFR M766Q Mutation in Lung Adenocarcinoma Mediates Osimertinib Resistance but is Sensitive to Neratinib and Poziotinib
Castellano, G. M., Aisner, J., Burley, S., Vallat, B., Yu, H. A., Pine, S. & Ganesan, S., Jan 1 2019, (Accepted/In press) In : Journal of Thoracic Oncology.Research output: Contribution to journal › Article
Exons
Mutation
Lung Neoplasms
N-(4-(3-chloro-4-(2-pyridinylmethoxy)anilino)-3-cyano-7-ethoxy-6-quinolyl)-4-(dimethylamino)-2-butenamide
HM781-36B
A phase 1b, multicenter, open-label, dose-finding study of eribulin in combination with carboplatin in advanced solid tumors and non-small cell lung cancer
Goel, S., Swami, U., Kumar, K., Dittrich, C., Reyderman, L., Jain, M., Aisner, J., Song, J. & Petrylak, D. P., Sep 1 2019, In : Cancer chemotherapy and pharmacology. 84, 3, p. 567-578 12 p.Research output: Contribution to journal › Article
eribulin
Carboplatin
Non-Small Cell Lung Carcinoma
Labels
Tumors
A phase I study of AT-101, a BH3 mimetic, in combination with paclitaxel and carboplatin in solid tumors
Stein, M., Goodin, S., Gounder, M., Gibbon, D., Moss, R., Portal, D., Lindquist, D., Zhao, Y., Takebe, N., Tan, A., Aisner, J., Lin, H., Ready, N. & Mehnert, J., Jan 1 2019, (Accepted/In press) In : Investigational New Drugs.Research output: Contribution to journal › Article
Carboplatin
Paclitaxel
Neoplasms
Area Under Curve
Prostate
A phase I trial of MK-2206 and hydroxychloroquine in patients with advanced solid tumors
Mehnert, J., Kaveney, A. D., Malhotra, J., Spencer, K., Portal, D., Goodin, S., Tan, A. R., Aisner, J., Moss, R. A., Lin, H., Bertino, J., Gibbon, D., Doyle, L. A., White, E. & Stein, M., Jan 1 2019, (Accepted/In press) In : Cancer chemotherapy and pharmacology.Research output: Contribution to journal › Article
Hydroxychloroquine
Tumors
Neoplasms
Exanthema
Fatigue
Association of Target Volume Margins With Locoregional Control and Acute Toxicities for Non-small cell lung cancer Treated With Concurrent Chemoradiation Therapy
Yegya-Raman, N., Reyhan, M., Kim, S., Deek, M. P., Yue, N., Zou, W., Malhotra, J., Aisner, J. & Jabbour, S., Jan 1 2019, In : Practical Radiation Oncology. 9, 1, p. e74-e82Research output: Contribution to journal › Article
Non-Small Cell Lung Carcinoma
Tumor Burden
Radiotherapy
Radiation Pneumonitis
Therapeutics